About Index Trending news
Analyze
Pricing
RA Capital Management

RA Capital Management

RA Capital Management

I work here Suggest edits
More info

Elsewhere

Also headquartered in Boston

DraftKings DraftKings General Electric General Electric Bain Capital Bain Capital Wikibon Wikibon Zipcar Zipcar Bolt Bolt Runkeeper Runkeeper MassChallenge MassChallenge The Boston Globe The Boston Globe Battery Ventures Battery Ventures

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Investments 31

Portfolio

Portfolio tracker
Add info

Investment profile

Target markets
Health Care Biotechnology Medical Devices

Activity

Past year's investments

- RA Capital Management participated in 9 rounds in the past year.
- The total disclosed amount of capital deployed in those rounds was $383,200,000 (averaging $42,577,778 per round).

Latest rounds

- Realm Therapeutics, Inc.: Post-IPO equity ($26M)
- Solid GT: Venture capital (Series C) ($50M)
- Dicerna Pharma: Post-IPO equity ($70M)

Main Co-investors

- Rock Springs Capital
- Perceptive Advisors
- Venrock

Zipline Medical

Zipline Medical

Health Care +1
Total funding
$47M in 6 rounds from 10 investors
By RA Capital Management
$5.7M Series C in Oct, 2014
Calhoun Vision, Inc.

Calhoun Vision, Inc.

Health Care +1
Total funding
$17M in 2 rounds from 5 investors
By RA Capital Management
$17M Debt financing in Jun, 2015
Clementia Pharmaceuticals Inc.

Clementia Pharmaceuticals Inc.

Pharmaceuticals
Total funding
$215.9M in 4 rounds from 11 investors
By RA Capital Management
$60M Series B in Jun, 2015
AveXis

AveXis

Biotechnology
Total funding
$75M in 2 rounds from 14 investors
By RA Capital Management
$65M Series D in Sep, 2015
Intarcia Therapeutics, Inc.

Intarcia Therapeutics, Inc.

Health Care +2
Total funding
$1.2B in 9 rounds from 25 investors
By RA Capital Management
$200M Private equity in Apr, 2014
Natera

Natera

Biotechnology
Total funding
$162.1M in 7 rounds from 23 investors
By RA Capital Management
$55.5M Series F in Apr, 2015
Blueprint Medicines

Blueprint Medicines

Health Care +1
Total funding
$240M in 4 rounds from 16 investors
By RA Capital Management
$50M Series C in Nov, 2014
Kala Pharmaceuticals

Kala Pharmaceuticals

Biotechnology
Total funding
$109.2M in 4 rounds from 23 investors
By RA Capital Management
$68M Series C in Apr, 2016
OvaScience

OvaScience

Health Care +1
Total funding
$90.8M in 2 rounds from 6 investors
By RA Capital Management
$37M Series B in Apr, 2012
Dicerna Pharma

Dicerna Pharma

Health Care +1
Total funding
$258M in 4 rounds from 18 investors
By RA Capital Management
$70M Post-IPO equity in Mar, 2017
T2 Biosystems

T2 Biosystems

Health Care +2
Total funding
$123.5M in 6 rounds from 34 investors
By RA Capital Management
$23M Series D in Aug, 2011
bluebird bio

bluebird bio

Biotechnology
Total funding
$384.3M in 5 rounds from 19 investors
By RA Capital Management
$60M Series D in Jul, 2012
Protagonist Therapeutics

Protagonist Therapeutics

Biotechnology
Total funding
$63M in 3 rounds from 13 investors
By RA Capital Management
$40M Series C in Jul, 2015
Arrowhead Research

Arrowhead Research

Biotechnology
Total funding
$114.6M in 3 rounds from 3 investors
By RA Capital Management
$60M Post-IPO equity in Oct, 2013
Bellicum Pharma

Bellicum Pharma

Biotechnology
Total funding
$127.5M in 4 rounds from 12 investors
By RA Capital Management
$94.4M Series C in Aug, 2014
Mitra Biotech

Mitra Biotech

Biotechnology
Total funding
$34.5M in 3 rounds from 10 investors
By RA Capital Management
$27.4M Series B in Aug, 2016
Spero Therapeutics

Spero Therapeutics

Biotechnology
Total funding
$84.7M in 4 rounds from 11 investors
By RA Capital Management
$51.7M Series C in Mar, 2017
Synthorx

Synthorx

Biotechnology +1
Total funding
$16M in 2 rounds from 4 investors
By RA Capital Management
$10M Series B in Jul, 2016
Cidara Therapeutics

Cidara Therapeutics

Health Care +2
Total funding
$100.9M in 4 rounds from 16 investors
By RA Capital Management
$42M Series B in Feb, 2015
G1 Therapeutics, Inc.

G1 Therapeutics, Inc.

Biotechnology
Total funding
$47M in 1 rounds from 12 investors
By RA Capital Management
$47M Series C in May, 2016
Antera Therapeutics

Antera Therapeutics

Biotechnology
Total funding
$1.7M in 1 rounds from 1 investors
By RA Capital Management
$1.7M Seed fund in Jun, 2016
Ascendis Pharma A/S

Ascendis Pharma A/S

Biotechnology
Total funding
$60M in 1 rounds from 6 investors
By RA Capital Management
$60M Series D in Dec, 2014
Biohaven Pharmaceuticals

Biohaven Pharmaceuticals

Biotechnology
Total funding
$100M in 2 rounds from 13 investors
By RA Capital Management
$80M Venture Capital in Nov, 2016
Shockwave Medical, Inc.

Shockwave Medical, Inc.

Health Care +1
Total funding
$132.5M in 4 rounds from 10 investors
By RA Capital Management
$45M Series C in Nov, 2016
Satsuma Pharmaceuticals

Satsuma Pharmaceuticals

Pharmaceuticals
Total funding
$12M in 1 rounds from 2 investors
By RA Capital Management
$12M Series A in Jan, 2017
Ivantis, Inc

Ivantis, Inc

Health and Wellness +2
Total funding
$39M in 2 rounds from 3 investors
By RA Capital Management
$25M Series C in Jan, 2017
AgriMetis LLC

AgriMetis LLC

Agriculture
Total funding
$30.8M in 2 rounds from 7 investors
By RA Capital Management
$23.5M Series B in Jan, 2017
Solid GT

Solid GT

Biotechnology
Total funding
$50M in 1 rounds from 9 investors
By RA Capital Management
$50M Series C in Mar, 2017
Realm Therapeutics, Inc.

Realm Therapeutics, Inc.

Biotechnology +1
Total funding
$26M in 1 rounds from 5 investors
By RA Capital Management
$26M Post-IPO equity in Sep, 2017

Want to see the complete list?
Go Pro!